성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,781명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Hematopoietic Growth Factors | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Hematopoietic Growth Factors

NCLEX Review Guide: Hematopoietic Growth Factors for Urinary & Renal Disorders

Erythropoiesis-Stimulating Agents (ESAs)

Epoetin Alfa (Epogen, Procrit) & Darbepoetin Alfa (Aranesp)

  • Mechanism of Action: Synthetic forms of erythropoietin that stimulate red blood cell production in bone marrow by mimicking natural erythropoietin hormone produced by kidneys.
  • Primary indication: Treatment of anemia associated with chronic kidney disease (CKD), especially in patients on dialysis or with severe renal impairment.
  • Target hemoglobin range: 10-12 g/dL - avoid exceeding 12 g/dL due to increased risk of cardiovascular events and stroke.
  • Administration routes include subcutaneous (preferred for CKD patients not on dialysis) and intravenous (common for dialysis patients).

Memory Aid: "ESA Safety"

Evaluate iron stores first
Slow increase in Hgb (1-2 g/dL per month)
Avoid Hgb >12 g/dL

Key Points

  • Iron supplementation is essential - ESAs cannot work effectively without adequate iron stores (ferritin >100 ng/mL, transferrin saturation >20%)
  • Monitor blood pressure closely - ESAs can cause hypertension due to increased blood viscosity
  • Black box warning: Increased risk of death, MI, stroke, and thromboembolism when targeting normal hemoglobin levels

Clinical Monitoring & Nursing Interventions

Assessment & Monitoring Parameters

  1. Obtain baseline CBC, iron studies (ferritin, transferrin saturation, serum iron), and blood pressure
  2. Monitor hemoglobin weekly initially, then every 2-4 weeks once stable
  3. Assess iron stores monthly - supplement iron if ferritin <100 ng/mL or transferrin saturation <20%
  4. Monitor blood pressure at each visit - may need antihypertensive therapy adjustment
  5. Evaluate for signs of thrombotic events (chest pain, shortness of breath, neurological changes)

Clinical Scenario

A 65-year-old patient with CKD stage 4 has Hgb 8.5 g/dL, ferritin 80 ng/mL, and transferrin saturation 15%. The physician orders epoetin alfa.

Nursing Action: Hold the epoetin alfa and notify physician. Patient needs iron supplementation first before starting ESA therapy to ensure effectiveness.

Key Points

  • Never start ESAs without adequate iron stores - this is a common NCLEX testing point
  • Hypertension is the most common side effect requiring close monitoring and potential medication adjustment

Commonly Confused Concepts

Epoetin Alfa Darbepoetin Alfa
Shorter half-life (24 hours) Longer half-life (49 hours)
Dosed 3x/week typically Dosed weekly or bi-weekly
More frequent monitoring needed Less frequent dosing adjustments

Key Points

  • Both drugs have the same mechanism and monitoring requirements - the main difference is dosing frequency
  • Darbepoetin's longer half-life makes it more convenient for patients not on dialysis

Contraindications & Special Considerations

Absolute Contraindications

  • Uncontrolled hypertension - ESAs can worsen blood pressure control and increase cardiovascular risk
  • Pure red cell aplasia (PRCA) - rare but serious condition where antibodies develop against erythropoietin
  • Hypersensitivity to mammalian cell-derived products or human albumin

Memory Aid: "STOP ESAs"

Severe hypertension
Thrombotic events
Overproduction (Hgb >12)
Pure red cell aplasia

Key Points

  • Cancer patients: Only use ESAs for chemotherapy-induced anemia, not for cancer-related anemia
  • Pregnancy category C - use only if benefits outweigh risks

Study Tips & Quick Checks

NCLEX Success Strategy

Remember the "Iron First" rule - always check iron stores before starting or if ESAs aren't working. This is frequently tested!

Quick Check Questions

  • ☐ Can you identify the target Hgb range for ESA therapy? (10-12 g/dL)
  • ☐ What lab values indicate adequate iron stores? (Ferritin >100, TSAT >20%)
  • ☐ What is the most common side effect requiring monitoring? (Hypertension)
  • ☐ When should ESAs be held? (Hgb >12, uncontrolled HTN, thrombotic events)

Common Pitfalls

Don't confuse ESAs with iron supplements - they work together but serve different purposes. ESAs stimulate RBC production, while iron provides the building blocks.

You're building the knowledge foundation for safe, effective nursing practice. Every concept you master brings you closer to becoming the nurse your patients need. Keep pushing forward - you've got this!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.